← Back to Vaccine Database

ABNCoV2 capsid virus-like particle (cVLP) +/- adjuvant MF59

Virus-like particle vaccine · VDDBV0028

Target & Classification

SARS-CoV-2SARS-CoV-2
Virus-like particle vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT04839146 Phase 1COVID-19
NCT05329220 Phase 3COVID-19